United States: Red Notice Newsletter - October 2016

DOJ Issues First Ever Declinations Requiring Disgorgement of Profits to Resolve FCPA Violations

On September 29, 2016, the Department of Justice (DOJ) for the first time announced declinations for two privately held companies while also requiring the companies to disgorge all profits attributable to their violations of the Foreign Corrupt Practices Act (FCPA). The DOJ stated that this new means for resolving cases is a result of the DOJ's FCPA Pilot Program announced in April 2016. Although, earlier this year, the DOJ announced declinations for three public companies that had previously disgorged their tainted profits to the Securities and Exchange Commission (SEC), the DOJ has not previously required disgorgement in connection with its own declinations.

The companies subject to declination with disgorgement, both privately held Texas companies, are HMT LLC, a manufacturer of above ground liquid storage tanks for the oil and gas industry, and NCH Corporation, a cleaning products manufacturer. According to the DOJ's declination letter, HMT paid about $500,000 in bribes to officials in Venezuela and China and will disgorge about $2.7 million in related profits. According to the DOJ's declination letter with respect to NCH, a China-based NCH subsidiary provided Chinese officials with about $44,000 in cash, gifts, meals and entertainment, generating profits of $335,000, which the company agreed to disgorge. Because of the companies' timely self-disclosure and full cooperation, the DOJ suspended its investigations in favor of compelling total disgorgement. The companies are also required to forego tax deductions for any portion of the disgorged amount.

For more information, read the DOJ letters here and here, as well as coverage in The FCPA Blog.

GlaxoSmithKline Settles China-Based FCPA Violations for $20 Million

Pharmaceutical giant GlaxoSmithKline plc (GSK) agreed to pay the SEC a $20 million civil penalty to settle charges related to an investigation into several of GSK's China-based subsidiaries for alleged violations of the internal controls and recordkeeping provisions of the FCPA.

According to the SEC's administrative order, from at least 2010 until June 2013, GSK's Chinese subsidiaries undertook various schemes to bribe Chinese officials, especially health care professionals, to increase sales of GSK products in China. These bribes were improperly recorded as legitimate expenses, such as conference fees, employee expenses and marketing costs, and tens of millions of dollars in expenses were found to be either inflated or fabricated to support events that never occurred. The SEC found that these illegal sales practices were widespread among the subsidiaries, noting that, in one instance, a regional manager approved arrangements that provided for holiday gifts to be given to a health care professional in exchange for his promise to prescribe 40 boxes of the GSK subsidiary's product each month.

In explaining the remediation factors that led to settlement, the SEC noted that GSK cooperated with the SEC's investigation and made global changes to its business practices, including eliminating payments to doctors for speaking about the company's prescription medicines and altering the compensation structure for its sales force to eliminate incentive pay based on the number of prescriptions generated.

For additional information, see the SEC notice and coverage in The FCPA Blog.

Grifols SA Announces Declination by DOJ

Spanish pharmaceutical company Grifols SA ("Grifols") announced in an SEC filing on October 7, 2016, that the DOJ is closing its investigation into potential FCPA violations without filing charges. This is the second declination received by the company since 2012. The 2012 declination related to certain conduct by the Talecris Group, prior to its acquisition by Grifols, in connection with sales to central and eastern European countries. Despite the DOJ's previous declination, the company indicated that it "continue[d] with the in-depth review of potential irregular practices" as recently as June 2016 as reflected in its Form 6K issued at that time.

For additional information, see the SEC notice and coverage in The FCPA Blog.

AC Boilers Faces Nine-Month World Bank Debarment and 15Month Conditional Non Debarment

On October 11, the World Bank announced the debarment of Italian boiler manufacturer AC Boilers SpA ("AC Boilers") and two of its affiliates for violation of the Bank's integrity compliance guidelines while bidding on a Bank-financed contract related to Egypt's El Tebbin Power Project. The Bank found that AC Boilers "recklessly failed to disclose" payments to, and the identities of, certain agents employed by the company during that bidding. AC Boilers and its affiliates – AC Boilers Egypt S.A.E. and Centro Combustione Ambiente – will face the nine-month debarment as part of a Negotiated Resolution Agreement between the company and the World Bank Integrity Vice Presidency. Following that nine-month period, AC Boilers and its affiliates will face an additional 15 months of conditional non debarment, during which time the companies can work on Bank projects if certain compliance conditions are satisfied. Additionally, prior to removal from the debarment list, each of the debarred companies will have to demonstrate compliance with the World Bank's Integrity Compliance Guidelines.

For additional information, see the Bank press release.


DDTC Announces Consent Agreement in Connection with Unauthorized Brokering of Weapons Destined for Libya

On October 5, 2016, the U.S. Department of State, Directorate of Defense Trade Controls (DDTC) announced a consent agreement with Marc Turi ("Turi") and Turi Defense Group, Inc. (TDG) in connection with unauthorized brokering activities and the unauthorized proposal for sale or transfer of defense articles to a Section 126.1 prohibited country. According to the DDTC charging letter, in 2011, Turi and TDG were denied a license request to engage in brokering activities involving light and heavy armaments and ammunition on behalf of the Libyan Transitional National Council. Around the same time, Turi and TDG were granted a license to engage in brokeringactivities on behalf of the government of Qatar for similar items. After receiving this license, DDTC alleged that Turi and TDG sent correspondence to individuals attempting to divert to Libya the defense articles approved in the Qatar transaction. The activities in question ultimately did not result in an export to Libya.

Turi and TDG settled with DDTC without admitting or denying the allegations, but agreed to a suspended $200,000 civil penalty. The penalty will be waived if they comply with the consent agreement, including refraining from participating in activities subject to the International Traffic in Arms Regulations for the next four years. In determining the penalty, DDTC considered the following mitigating factors: investigative cooperation, the belief that the activities were authorized, agreement to toll the statute of limitations and the absence of a transfer of defense articles to Libya.

For additional information, please see the DDTC charging letter, consent agreement and order.

New York Resident and Two Russian Nationals Arrested for Alleged Conspiracy to Export Advanced Microelectronics from the United States to Russia

On October 6, 2016, the U.S. Department of Justice (DOJ) announced that federal agents arrested a naturalized U.S. citizen and two Russian nationals for engaging in a conspiracy to export advanced microelectronics from the United States to Russia. The items in question include digital-to-analog converters and integrated circuits used in radar and surveillance systems, missile guidance systems and satellites. Such items are controlled by the Department of Commerce's (DOC) Bureau of Industry and Security (BIS) for national security reasons and cannot be exported to Russia without a license. DOJ alleges that the individuals used two Brooklyn-based front companies to evade export controls by providing false enduser information to suppliers and falsely classifying exported goods on documents submitted with the DOC. To further conceal the destination of the exports, the individuals shipped the items first to Finland and then to Russia. If convicted, the individuals face up to 25 years in prison and a $1 million fine.

For additional information, please see the DOJ press release.

Two Individuals Sentenced in Connection with Illegal Exports to Syria

On October 26, 2016, the U.S. Attorney's Office for the Middle District of Pennsylvania announced that two individuals were sentenced for conspiring to export illegal goods to Syria, including a portable multi-gas scanner for the detection of chemical warfare agents. According to the press release, one of the individuals operated an export business in Hallstead, Pennsylvania, and conspired with the other to export items from the United States to customers in Syria through third countries. The individuals evaded U.S. export controls by preparing false invoices, which undervalued and mis-labeled the goods being purchased and also listed false information regarding the identity and geographic location of the purchasers of the goods. One of the individuals was sentenced to a 37month prison term and ordered to forfeit $45,698. The other was sentenced to 12 months of home confinement, a fine of $2,600 and a term of supervised release of two years, and was ordered to forfeit $45,698.

For additional information, please see the DOJ press release.

New Round of Cuba Sanctions Changes Expand Opportunities for Health Sector

On October 17, 2016, the Office of Foreign Assets Control (OFAC) and BIS implemented amendments to the Cuban Assets Control Regulations and Export Administration Regulations, respectively, that further ease U.S. sanctions and export controls targeting Cuba, particularly in the areas of medical research, pharmaceuticals, and trade and commerce between the United States and Cuba. These changes continue the administration's policy of easing sanctions on Cuba to support the Cuban people and follow prior regulatory changes that occurred in January 2015, September 2015, January 2016 and March 2016.

This latest round of changes by the Obama administration provide new opportunities for U.S. companies operating in the health sector to engage in joint research activities with Cuban nationals and obtain Food and Drug Administration approval for and commercialize Cuban-origin pharmaceuticals. Additionally, the changes make it easier for U.S. companies to negotiate transactions with Cuban counterparties that require OFAC approval by allowing them to negotiate and execute "contingent contracts" that are expressly contingent on OFAC authorization or such authorization being no longer required. Notwithstanding these latest changes, the U.S. embargo against Cuba continues to broadly restrict trade, financial services and travel between the two countries, absent general or specific authorization by OFAC and/or BIS.

For additional information, please see the OFAC press release on the updated regulations and the Presidential Policy Directive issued by the White House Office of the Press Secretary. Additional discussion and analysis is provided in the Akin Gump International Trade Alert from October 19, 2016.

OFAC Issues Guidance on U.S. Dollar Transactions Involving Iran

On October 7, 2016, OFAC updated its Frequently Asked Questions regarding U.S. sanctions on Iran. The updated guidance clarifies (i) the circumstances under which nonU.

S. financial institutions may engage in U.S. dollar transactions involving Iran (ii) when residual "secondary" U.S. sanctions on Iran can affect transactions involving affiliates of Iranian Specially Designated Nationals and (iii) U.S. government expectations for conduct of compliance screening and due diligence in Iran-related transactions otherwise permissible under U.S. sanctions relief implemented pursuant to the Joint Comprehensive Plan of Action (JCPOA) in January 2016. These clarifications are particularly relevant for transactions involving non-U.S. financial services institutions. Such institutions have generally been reluctant to support or participate in Iran-related transactions, despite the sanctions relief measures under the JCPOA implemented by the United States and the European Union.

Please see the OFAC press release for additional information, as well as the discussion on the impact of this new guidance in the Akin Gump International Trade Alert from October 11, 2016.

President Issues Executive Order Terminating Sanctions on Myanmar

On October 7, 2016, President Obama issued an Executive Order that effectively lifts all sanctions against Myanmar by terminating the longstanding national emergency relating to Burma (aka Myanmar) and revoking the Executive Orders that authorized past sanctions. Accordingly, OFAC announced that all property and interests in property that had been blocked pursuant to the Burmese Sanctions Regulation (BSR) are now unblocked.

The development follows over four years of White House engagement with the government of Myanmar to improve relations. The two governments now intend to work together toward a bilateral investment treaty, improvements to labor standards and human rights, and to combat money laundering, corruption and trafficking.

Nonetheless, OFAC still retains authority to continue or initiate investigations and enforcement actions for apparent violations of the BSR that were in effect at the time of the underlying activities. Political and reputational risks also remain in relation to doing business in the country. In light of the above, businesses considering new opportunities in the country will need to ensure a proper read of the dynamic U.S.Myanmar relationship moving forward.

For additional information, please see the discussion in the Akin Gump International Trade Alert.

On November 12, Christian Davis will speak at the EAR and ITAR Enforcement Seminars hosted by the Export Compliance Training Institute in Alexandria, VA.

On November 14, Rebekah Jones will speak on the preconference working group titled "How to Conduct Effective Third Party Due Diligence When Data Is Unavailable or Unreliable: How Far You Have to Go to Vet a ThirdParty PostPanama Paper and Unaoil" at the American Conference Institute (ACI) AsiaPacific Summit on Anticorruption Compliance and Risk Management in Singapore.

On November 15, Natasha Kohne will be presenting on "Lessons Learned from Cybersecurity & Data Protection Roundtable: Role of GC" at the RSA Conference in Abu Dhabi.

On November 17, Tatman R. Savio will speak on the panel titled "Iran Sanctions–Perception vs. Reality: What Is and Is Not Allowed for Companies and Their Subsidiaries, and a Practical Review of General Licenses H, I, G" at the American Conference Institute (ACI) Asia Summit on Economic Sanctions Compliance and Enforcement in Singapore. If you would like to invite Akin Gump lawyers to speak at your company or to your group about anticorruption law, compliance, cybersecurity, enforcement and policy or other international investigation and compliance topics, please contact Mandy Warfield at mwarfield@akingump.com or +1 202.887.4464.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Akin Gump Strauss Hauer & Feld LLP
Akin Gump Strauss Hauer & Feld LLP
Akin Gump Strauss Hauer & Feld LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Akin Gump Strauss Hauer & Feld LLP
Akin Gump Strauss Hauer & Feld LLP
Akin Gump Strauss Hauer & Feld LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions